Search research articles
Contact Us
Filters
Showing results (111-120 of 175) with videos related to
Page
of 18
Sort By:
The Journal of Urology
|
July 13, 2010
Low frequency of epigenetic events in urothelial tumors in young patients
Helen C Owen, J Giedl, Peter J Wild, et al.
The Journal of Urology
|
December 24, 2019
Long-Term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience
Sigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
Urology Practice
|
May 5, 2023
Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized Cohort
Samson W Fine, Hikmat A Al-Ahmadie, Emily Vertosick, et al.
The Journal of Urology
|
October 16, 2007
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities
Scott E Eggener, Peter T Scardino, Peter R Carroll, et al.
The Journal of Urology
|
October 16, 2012
Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade
Kazuma Udo, Angel M Cronin, Lauren J Carlino, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 9, 2024
L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma
Mohammed Alghamdi, Jie-Fu Chen, Achim Jungbluth, et al.
Cancer Research
|
February 5, 2009
TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy
Anuradha Gopalan, Margaret A Leversha, Jaya M Satagopan, et al.
Clinical Genitourinary Cancer
|
September 11, 2024
Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active Surveillance
Marlon Perera, Melissa Assel, Sunny Nalavenkata, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 10, 2019
Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile
Judy Sarungbam, Rohit Mehra, Scott A Tomlins, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 4, 2020
Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinoma
Chen Yang, Robert S Cimera, Ruth Aryeequaye, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 175) with videos related to
Sort By:
Page
of 18
The Journal of Urology
|
July 13, 2010
Low frequency of epigenetic events in urothelial tumors in young patients
Helen C Owen, J Giedl, Peter J Wild, et al.
The Journal of Urology
|
December 24, 2019
Long-Term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience
Sigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
Urology Practice
|
May 5, 2023
Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized Cohort
Samson W Fine, Hikmat A Al-Ahmadie, Emily Vertosick, et al.
The Journal of Urology
|
October 16, 2007
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities
Scott E Eggener, Peter T Scardino, Peter R Carroll, et al.
The Journal of Urology
|
October 16, 2012
Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade
Kazuma Udo, Angel M Cronin, Lauren J Carlino, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 9, 2024
L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma
Mohammed Alghamdi, Jie-Fu Chen, Achim Jungbluth, et al.
Cancer Research
|
February 5, 2009
TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy
Anuradha Gopalan, Margaret A Leversha, Jaya M Satagopan, et al.
Clinical Genitourinary Cancer
|
September 11, 2024
Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active Surveillance
Marlon Perera, Melissa Assel, Sunny Nalavenkata, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 10, 2019
Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile
Judy Sarungbam, Rohit Mehra, Scott A Tomlins, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 4, 2020
Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinoma
Chen Yang, Robert S Cimera, Ruth Aryeequaye, et al.
Page
of 18